Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestorsHeatmap
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
PACB
Pacific Biosciences of California, Inc. PACB
$1.38
โ–ผ -2.96% 24H
0.9213.2725.6237.9750.322010-102014-092018-082022-072026-06

About

Pacific Biosciences of California, Inc. is a biotechnology company that develops, manufactures, and markets advanced DNA sequencing systems for genetic analysis. The company focuses on high-accuracy long-read and complementary short-read sequencing technologies that enable comprehensive characterization of genomes, traโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees485
TickerPACB

Statistics

Market Cap$426.9M
Revenue (TTM)$160.0M
Net Income-$546.4M
Net Margin-341.5%
EPS$-0.41
P/E-0.75
P/S2.62
P/B168.75
EV/EBITDA-5.98
ROE-273.6%
Dividend Yieldโ€”
Price$1.38

Data: Twelve Data ยท Revenue = mcap / P/S

Pacific Biosciences of California, Inc. (PACB) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap